Abstract |
Overexpression of nuclear receptor coactivators is a frequent event in breast cancer cells and is recognized as a key mechanism for these cells to maximize their oncogenic growth state. Steroid receptor coactivator-3 [(SRC-3), also known as amplified in breast cancer-1 or AIB1] is foremost among these overexpressed oncogenic coactivators, being overexpressed in most breast cancers. Because of its oncogenic potential, normal cells must carefully control its cellular concentration. We discuss how SRC-3 quantitatively influences estrogen-regulated gene transcription when it is at limiting concentrations in normal breast cells and at nonlimiting concentrations in breast cancer cells. Precise control of the cellular concentration of SRC-3 may thus serve as a mechanism for defining growth responses to estrogen receptors and other growth-promoting transcription factors.
|
Authors | David M Lonard, Bert W O'Malley |
Journal | Science signaling
(Sci Signal)
Vol. 1
Issue 13
Pg. pe16
(Apr 01 2008)
ISSN: 1937-9145 [Electronic] United States |
PMID | 18385039
(Publication Type: Journal Article)
|
Chemical References |
- Trans-Activators
- Ubiquitin
- Histone Acetyltransferases
- NCOA3 protein, human
- Nuclear Receptor Coactivator 3
|
Topics |
- Cell Line, Tumor
- Histone Acetyltransferases
(physiology)
- Humans
- Nuclear Receptor Coactivator 3
- Trans-Activators
(physiology)
- Transcriptional Activation
- Ubiquitin
(physiology)
|